Skin Removal After Weight Loss Surgery: What to Know

Dec. 6, 2022 – Rosalina Finelli from Deerfield Beach, FL, lost 216 pounds after weight loss surgery in November 2019. While she wanted to celebrate her achievement, the procedure left her with excess skin on her arms, back, chest, belly, and upper thighs. Finelli says she constantly felt pressure from the hanging skin on her […]

Continue Reading

More States Are Allowing Pharmacists to Prescribe Birth Control

By Cara Murez  HealthDay Reporter TUESDAY, Dec. 6, 2022 (HealthDay News) — Pharmacists can now prescribe hormonal contraceptives in 20 U.S. states, plus Washington, D.C., giving women easier access to birth control, a new report says. Another 10 states have legislation in the works, according to research presented Monday at a meeting of the American […]

Continue Reading

Tiny, Menacing Microclots May Explain Long COVID’s Symptoms

SOURCES: Hannah Davis, founding member and researcher, Patient-Led Research Collaborative. Etheresia (Resia) Pretorius, PhD, head of department and distinguished research professor, Physiological Sciences Department, Faculty of Science, Stellenbosch University, South Africa. Douglas Kell, PhD, research chair in systems biology, Department of Biochemistry, University of Liverpool, U.K. Michael VanElzakker, PhD, neuroscientist, Massachusetts General Hospital and Harvard Medical School; […]

Continue Reading

Get Ready to Share the Road with a Self-Driving Vehicle

Dec. 8, 2022 – What are the cars of the future, and what impact could they have on public health? Drivers around Silicon Valley have glanced out their car window to see the vehicle cruising alongside them has no one in the driver’s seat. Tech companies in California have been testing their new self-driving vehicles, […]

Continue Reading

Antibody Drug Boosts Survival for Type of Advanced Breast Cancer

By Dennis Thompson  HealthDay Reporter THURSDAY, Dec. 8, 2022 (HealthDay News) — A relatively new drug is boosting survival rates for women with a specific type of advanced breast cancer who haven’t responded to other treatments, according to a pair of clinical trials.  The targeted antibody drug — trastuzumab deruxtecan (T-DXd, sold under the brand […]

Continue Reading